Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit

Clinica Chimica Acta

Volumn 419, Issue , 2013, Pages 136-138

  Singh, Harsh Vardhan ^a   Pandey, Aparna ^b   Shrivastava, Amit Kumar ^c   Raizada, Arun ^d   Singh, Sanjeev Kumar ^e   Singh, Neelima ^e  

^a HINDU RAO HOSPITAL   (India)

^b Narsinhbhai Patel Dental College and Hospital   (India)

^c Sudha Rustagi College of Dental Sciences and Research   (India)

^d Medanta The Medicity ^*  (India)

^e G R MEDICAL COLLEGE   (India)

Author keywords

Interleukin 10 (IL 10); Ischemic stroke; National Institute of Health Stroke Scale (NIHSS); Neuron Specific Enolase (NSE)

Indexed keywords

INTERLEUKIN 10; NEURON SPECIFIC ENOLASE;

ADULT; ARTICLE; BLOOD ANALYSIS; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS;

BRAIN ISCHEMIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PHOSPHOPYRUVATE HYDRATASE; STROKE;

EID: 84875263352     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.02.014     Document Type: Article

References (27)

1. Marangos P.J., Zomzely-Neurath C., Goodwin F.K. Structural and immunological properties of neuron specific protein (NSP) from rat, cat and human brain: comparison to bovine 14-3-2. J Neurochem 1977, 28:1097-1107.
2. Marangos P.J., Schmechel D.E. Neuron specific enolase: a clinically useful marker of neurons and neuroendocrine cells. Annu Rev Neurosci 1987, 10:269-295.
3. Anand N., Stead L.G. Neuron-specific enolase as a marker for acute ischemic stroke: a systematic review. Cerebrovasc Dis 2005, 20:213-219.
4. Wunderlich M.T., Ebert A.D., Kratz T., et al. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999, 30:1190-1195.
5. Oh S.H., Lee J.G., Na S.J., et al. The effect of initial serum neuron-specific enolase level on clinical outcome in acute carotid artery territory infarction. Yonsei Med J 2002, 43:357-362.
6. Basic Kes V., Simundic A.M., Nikolac N., et al. Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. Clin Biochem 2008, 41:1330-1334.
7. Exel E.V., Gussekloo J., de Craen A.J.M., et al. Inflammation and stroke: the Leiden 85-plus study. Stroke 2002, 33:1135-1138.
8. Nomoto T., Okada T., Shimazaki K., et al. Systemic delivery of IL-10 by an AAV vector prevents vascular remodeling and end-organ damage in stroke-prone spontaneously hypertensive rat. Gene Ther 2009, 16:383-391.
9. Bachis A., Colangelo A.M., Vicini S., et al. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J Neurosci 2001, 21:3104-3112.
10. + T cells. J Immunol 2003, 171:6549-6555.
11. Spera P.A., Ellison J.A., Feuerstein G.Z., Barone F.C. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 1998, 251:189-192.
12. Wu Y.C., Zhao Y.B., Lu C.Z., et al. Correlation between serum level of neuron-specific enolase and long-term functional outcome after acute cerebral infarction: prospective study. Hong Kong Med J 2004, 10:251-254.
13. Horn M., Schlote W. Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemia. Acta Neuropathol 1992, 85:79-87.
14. Takei N., Kondo J., Nagaike K., et al. Neuronal survival factor from bovine brain is identical to neuron-specific enolase. J Neurochem 1991, 57:1178-1184.
15. Cunningham R.T., Young I.S., Winder J., et al. Serum neuron-specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest 1991, 32:497-500.
16. González-García S., González-Quevedo A., Peña-Sánchez M., et al. Serum neuron-specific enolase and S100 calcium binding protein B biomarker levels do not improve diagnosis of acute stroke. J R Coll Physicians Edinb 2012, 42:199-204.
17. Al-Rawi N.H., Atiyah K.M. Salivary neuron specific enolase: an indicator for neuronal damage in patients with ischemic stroke and stroke-prone patients. Clin Chem Lab Med 2009, 47:1519-1524.
18. Sulter G., Elting J.W., De Keyser J. Increased serum neuron specific enolase concentrations in patients with hyperglycemic cortical ischemic stroke. Neurosci Lett 1998, 253:71-73.
19. Sandhu H.S., Butt A.N., Powrie J., Swaminathan R. Measurement of circulating neuron-specific enolase mRNA in diabetes mellitus. Ann N Y Acad Sci 2008, 1137:258-263.
20. Brea D., Sobrino T., Blanco M., et al. Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke. Clin Chem Lab Med 2009, 47:1513-1518.
21. Fassbender K., Schmidt R., Schreiner A., et al. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci 1997, 148:101-105.
22. Missler U., Wiesmann M., Friedrich C., Kaps M. S-100 protein and neuron specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997, 28:1956-1960.
23. Geng Y., Gulbins E., Altman A., Lotz M. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc Natl Acad Sci U S A 1994, 91:8602-8606.
24. Howard M., O'Garra A. Biological properties of interleukin-10. Immunol Today 1992, 13:198-200.
25. Frenkel D., Huang Z., Maron R., et al. Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J Neurol Sci 2005, 233:125-132.
26. Morita Y., Takizawa S., Kamiguchi H., et al. Administration of hematopoietic cytokines increases the expression of anti-inflammatory cytokine (IL-10) mRNA in the subacute phase after stroke. Neurosci Res 2007, 58:356-360.
27. Perini F., Morra M., Alecci M., et al. Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurol Sci 2001, 22:289-296.